Landfar Bio-medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	162.82	207.36	493.81	218.15	153	67.04
Trading Asset Securities	100.46	0.61	1.72	1.69	0.5	0.66
Cash & Short-Term Investments	263.28	207.97	495.53	219.83	153.51	67.7
Cash Growth	-16.49%	-58.03%	125.41%	43.21%	126.76%	-3.78%
Accounts Receivable	143.51	139.58	123.22	158.76	197.92	198.54
Other Receivables	24.01	13.62	19.35	27.67	8.82	23.95
Receivables	167.53	153.2	142.57	186.43	206.74	222.49
Inventory	46.25	34.06	10.66	4.5	10.64	14.93
Prepaid Expenses	-	0.16	0.07	0.03	0.57	0.07
Other Current Assets	40.38	6.51	6.02	5.44	145.17	174.52
Total Current Assets	517.44	401.9	654.85	416.24	516.62	479.7
Property, Plant & Equipment	176.46	26.05	28.06	35.93	35.85	11.6
Long-Term Investments	-	100	5.42	5.48	5.98	6.3
Goodwill	1.98	1.98	1.98	8.44	8.44	11.23
Other Intangible Assets	62.37	1.86	0.44	0.36	0.22	1.54
Long-Term Accounts Receivable	-	0.03	0.04	0.06	0.07	1.85
Long-Term Deferred Tax Assets	8.28	1.92	1.11	0.6	1.05	0.96
Long-Term Deferred Charges	75.4	73.75	79.48	85.67	89.58	41.45
Other Long-Term Assets	0.03	0.67	-	0.58	1.44	1.51
Total Assets	841.96	608.17	771.38	553.37	659.25	556.14
Accounts Payable	94.69	84.47	82.21	82.03	89.56	60.69
Accrued Expenses	3.23	8.03	9.01	8.61	6.17	10.19
Short-Term Debt	43.04	-	187.71	218.73	293.06	271.62
Current Portion of Long-Term Debt	1.58	1	-	-	-	-
Current Portion of Leases	-	3.61	3.16	2.81	2.35	-
Current Income Taxes Payable	2.7	2.58	1.62	7.19	4.88	5.11
Current Unearned Revenue	194.63	185.18	151.41	119.74	123.84	63.29
Other Current Liabilities	24.48	20.61	17.28	16.04	9.14	7.37
Total Current Liabilities	364.36	305.47	452.4	455.15	529	418.26
Long-Term Debt	75.49	9	-	-	-	-
Long-Term Leases	9.68	10.45	13	14.79	16.89	-
Long-Term Unearned Revenue	23.15	1.1	1.06	1.83	1.4	1.22
Long-Term Deferred Tax Liabilities	6.63	0.15	0.25	0.41	0.64	1.18
Other Long-Term Liabilities	-	-	-	1	1	1
Total Liabilities	479.3	326.17	466.71	473.18	548.93	421.66
Common Stock	330.02	330.02	330.02	311.57	311.57	311.57
Additional Paid-In Capital	423.47	423.47	423.47	170.82	160.99	151.79
Retained Earnings	-511.17	-516.4	-496.55	-468.38	-455.92	-436.8
Total Common Equity	242.33	237.1	256.94	14.01	16.64	26.57
Minority Interest	120.33	44.9	47.73	66.18	93.68	107.91
Shareholders' Equity	362.66	282	304.67	80.19	110.32	134.48
Total Liabilities & Equity	841.96	608.17	771.38	553.37	659.25	556.14
Total Debt	129.78	24.06	203.87	236.33	312.29	271.62
Net Cash (Debt)	133.49	183.91	291.66	-16.5	-158.79	-203.92
Net Cash Growth	-53.42%	-36.94%	-	-	-	-
Net Cash Per Share	0.40	0.56	0.93	-0.05	-0.50	-0.75
Filing Date Shares Outstanding	330.02	330.02	330.02	311.57	311.57	311.57
Total Common Shares Outstanding	330.02	330.02	330.02	311.57	311.57	311.57
Working Capital	153.08	96.43	202.45	-38.92	-12.38	61.44
Book Value Per Share	0.73	0.72	0.78	0.04	0.05	0.09
Tangible Book Value	177.98	233.25	254.52	5.21	7.98	13.79
Tangible Book Value Per Share	0.54	0.71	0.77	0.02	0.03	0.04
Buildings	-	-	-	12.94	12.94	12.94
Machinery	-	25.09	23.4	22.39	16.85	10.75
Construction In Progress	-	-	-	-	1.29	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.